Combo Drug Test
Benzodiazepines/Ketamine/Gamma-Hydroxybutyric Acid Combo Rapid Test (BZO/KET/GHB)
Simultaneously detect Benzodiazepines, Ketamine, and GHB in urine.
CE Certified
ISO 13485
Why Choose reOpenTest Toxicology & Drug Monitoring Kits?
Our tests are engineered for accuracy, reliability, and ease of use, ensuring confidence in every result.
Multi-Drug Detection
Simultaneous detection of three substances.
Rapid Results
Fast results in 10-15 minutes.
Easy to Interpret
Simple, user-friendly format.
Product Overview
The Benzodiazepines/Ketamine/Gamma-Hydroxybutyric Acid Combo Rapid Test (BZO/KET/GHB) is a qualitative immunoassay for the simultaneous detection of benzodiazepines, ketamine, and gamma-hydroxybutyric acid (GHB) in urine samples.
Technical Specifications
| Detection Target | Benzodiazepines, Ketamine, Gamma-Hydroxybutyric Acid (GHB) |
|---|---|
| Sample Type | Urine |
| Methodology | Immunochromatography |
| Detection Range | Qualitative (Positive/Negative) |
| Reaction Time | 10-15 minutes |
| Storage Conditions | 2-30u00b0C |
| Shelf Life | 18 months |
Procedure & Interpretation
Step-by-Step Procedure
- Collect urine sample.
- Apply urine sample to the device.
- Read results after 10-15 minutes.
Result Interpretation
Positive:
Presence of one or more drugs detected.
Negative:
No drugs detected.
Invalid:
Test is invalid. Repeat with a new device.
Frequently Asked Questions
This test is designed for presumptive screening of benzodiazepines, ketamine, and GHB in urine.
Yes, results should be confirmed with more sophisticated laboratory techniques.
Store at 2-30u00b0C.
Technical Documents
Download product inserts and brochures for detailed information.
No technical documents are available at this time. Please check back soon.
Partner with reOpenTest
Provide your clients and patients with reliable diagnostic solutions.
Contact us today for bulk pricing and distribution opportunities.